June 8, 2015
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on Drugs, an advisory panel to the health minister, on June 5 recommended approval for Eli Lilly Japan’s once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist dulaglutide. If approved, dulaglutide will be...read more